Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

Sadia Waheed; Angel Bayas; Fawzi Hindi; Zufe Rizvi; Patricio S Espinosa

doi:10.7759/cureus.13426

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

Cureus. 2021 Feb 18;13(2):e13426. doi: 10.7759/cureus.13426.

Authors

Sadia Waheed¹, Angel Bayas¹, Fawzi Hindi¹, Zufe Rizvi¹, Patricio S Espinosa¹

Affiliation

¹ Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.

Abstract

Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.

Keywords: covid-19 vaccine; guillain-barre syndrome (gbs); neurologic complications.

Publication types

Case Reports